Business Description
Clal Biotechnology Industries Ltd
ISIN : IL0011042806
Description
Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.41 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.39 | |||||
| Debt-to-EBITDA | 0.58 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -9.11 | |||||
| Beneish M-Score | -2.88 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 86.7 | |||||
| 3-Year FCF Growth Rate | 37.9 | |||||
| 3-Year Book Growth Rate | -30.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.52 | |||||
| 9-Day RSI | 30 | |||||
| 14-Day RSI | 34.95 | |||||
| 6-1 Month Momentum % | 6.05 | |||||
| 12-1 Month Momentum % | -9.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.18 | |||||
| Quick Ratio | 2.18 | |||||
| Cash Ratio | 2.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.9 | |||||
| Shareholder Yield % | -14.51 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -25396.88 | |||||
| Net Margin % | -233553.13 | |||||
| FCF Margin % | -25159.38 | |||||
| ROE % | -76.36 | |||||
| ROA % | -48.67 | |||||
| ROIC % | -5.65 | |||||
| ROC (Joel Greenblatt) % | 1070.24 | |||||
| ROCE % | 26.69 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 340 | |||||
| PB Ratio | 0.89 | |||||
| Price-to-Tangible-Book | 0.89 | |||||
| EV-to-EBIT | 2.26 | |||||
| EV-to-EBITDA | 2.24 | |||||
| EV-to-Revenue | 2804.28 | |||||
| EV-to-FCF | -11.15 | |||||
| Price-to-Median-PS-Value | 17 | |||||
| Earnings Yield (Greenblatt) % | 44.25 | |||||
| FCF Yield % | -15.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Clal Biotechnology Industries Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 0.032 | ||
| EPS (TTM) (₪) | -0.48 | ||
| Beta | 0 | ||
| Volatility % | 46.07 | ||
| 14-Day RSI | 34.95 | ||
| 14-Day ATR (₪) | 0.010232 | ||
| 20-Day SMA (₪) | 0.35495 | ||
| 12-1 Month Momentum % | -9.8 | ||
| 52-Week Range (₪) | 0.29 - 0.53 | ||
| Shares Outstanding (Mil) | 156.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Clal Biotechnology Industries Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Clal Biotechnology Industries Ltd Stock Events
| Event | Date | Price(₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
Clal Biotechnology Industries Ltd Frequently Asked Questions
What is Clal Biotechnology Industries Ltd(XTAE:CBI)'s stock price today?
The current price of XTAE:CBI is ₪0.34. The 52 week high of XTAE:CBI is ₪0.53 and 52 week low is ₪0.29.
When is next earnings date of Clal Biotechnology Industries Ltd(XTAE:CBI)?
The next earnings date of Clal Biotechnology Industries Ltd(XTAE:CBI) is .
Does Clal Biotechnology Industries Ltd(XTAE:CBI) pay dividends? If so, how much?
Clal Biotechnology Industries Ltd(XTAE:CBI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers